Literature DB >> 7806155

Changes in fatty acid composition of plasma, liver microsomes, and erythrocytes in liver cirrhosis induced by oral intake of thioacetamide in rats.

E Moreira1, L Fontana, J L Periago, F Sanchéz De Medina, A Gil.   

Abstract

The aim of this study was to evaluate the changes in fatty acid composition of lipids of plasma, erythrocytes, and liver microsomes in rats with liver cirrhosis induced by oral intake of thioacetamide and to determine to what extent the experimental model reproduces the fatty acid tissue alterations reported in human cirrhosis. Two groups of rats were studied. The control group received water ad libitum, and the experimental group received 0.03% w/v thioacetamide in drinking water for 2, 4, and 6 months. At these times, lipids of plasma, erythrocytes, and liver microsomes were extracted, and their fatty acid compositions were determined. Thioacetamide intake led to macronodular and micronodular cirrhosis at 2 months. These alterations progressed at 4 months and eventuated in liver tumors at 6 months. Thioacetamide-treated rats showed a drop in total plasma fatty acids, higher percentages of palmitic acid in all lipid fractions, and lower levels of stearic acid in erythrocyte lipids and liver microsomal phospholipids. Oleic acid increased in plasma cholesteryl esters and phospholipids, as well as in erythrocyte lipids and liver microsomal phospholipids. In plasma lipids and liver microsomal phospholipids, the percentages of arachidonic and docosahexaenoic acids decreased. The latter also decreased in erythrocyte lipids. In addition, liver microsomes showed a higher cholesterol/lipid phosphorus molar ratio. The experimental model of cirrhosis obtained by intake of thioacetamide in drinking water for 4 months reproduces many of the fatty acid tissue alterations that appear in human cirrhosis and may serve to ascertain the biochemical mechanisms involved in these changes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7806155

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

1.  Modulation of AP-endonuclease1 levels associated with hepatic cirrhosis in rat model treated with human umbilical cord blood mononuclear stem cells.

Authors:  Ahmad R Bassiouny; Amira Z Zaky; Shaymaa A Abdulmalek; Kamal M Kandeel; Alaa Ismail; Marie Moftah
Journal:  Int J Clin Exp Pathol       Date:  2011-10-16

2.  Hepatic injury due to combined choline-deprivation and thioacetamide administration: an experimental approach to liver diseases.

Authors:  Hussam Al-Humadi; Stamatios Theocharis; Ismene Dontas; Vasileios Stolakis; Apostolos Zarros; Argyro Kyriakaki; Rafal Al-Saigh; Charis Liapi
Journal:  Dig Dis Sci       Date:  2012-07-10       Impact factor: 3.199

3.  Serine dehydratase expression decreases in rat livers injured by chronic thioacetamide ingestion.

Authors:  Inmaculada López-Flores; Juan B Barroso; Raquel Valderrama; Francisco J Esteban; Esther Martínez-Lara; Francisco Luque; M Angeles Peinado; Hirofumi Ogawa; José A Lupiáñez; Juan Peragón
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

4.  Endotoxins enhance hepatocarcinogenesis induced by oral intake of thioacetamide in rats.

Authors:  Jin-Ming Yang; De-Wu Han; Chun-Ming Xie; Quan-Cheng Liang; Yuan-Chang Zhao; Xue-Hui Ma
Journal:  World J Gastroenterol       Date:  1998-04       Impact factor: 5.742

5.  Hepatotoxic agent thioacetamide induces biochemical and histological alterations in rat small intestine.

Authors:  M A Ortega; M I Torres; M I Fernández; A Rios; A Sánchez-Pozo; A Gil
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

6.  Influence of administration of long-chain polyunsaturated fatty acids on process of histological recovery in liver cirrhosis produced by oral intake of thioacetamide.

Authors:  I Fernández; I Torres; E Moreira; L Fontana; A Gil; A Rios
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

7.  Silymarin Protects Mouse Liver and Kidney from Thioacetamide Induced Toxicity by Scavenging Reactive Oxygen Species and Activating PI3K-Akt Pathway.

Authors:  Shatadal Ghosh; Abhijit Sarkar; Sudip Bhattacharyya; Parames C Sil
Journal:  Front Pharmacol       Date:  2016-12-15       Impact factor: 5.810

8.  Amelioration of thioacetamide-induced liver toxicity in Wistar rats by rutin.

Authors:  Seema Zargar; Tanveer A Wani; Abir Abdullah Alamro; Majid Ahmad Ganaie
Journal:  Int J Immunopathol Pharmacol       Date:  2017-06-07       Impact factor: 3.219

9.  Resveratrol Reverses Thioacetamide-Induced Renal Assault with respect to Oxidative Stress, Renal Function, DNA Damage, and Cytokine Release in Wistar Rats.

Authors:  Seema Zargar; Mona Alonazi; Humaira Rizwana; Tanveer A Wani
Journal:  Oxid Med Cell Longev       Date:  2019-09-10       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.